Article Information
History
- February 7, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Farnaz Fekri1,2,
- John Abousawan1,2,
- Stephen Bautista1,2,
- Roya M. Dayam1,2,
- Costin N. Antonescu1,2,5,* and
- Raffi Karshafian2,3,4,5,*
- 1Department of Chemistry and Biology Ryerson University, Toronto Ontario, Canada, M5B 2K3
- 2Graduate Program in Molecular Science, Toronto Ontario, Canada, M5B 2K3
- 3Department of Physics, Ryerson University, Toronto Ontario, Canada, M5B 2K3
- 4Institute for Biomedical Engineering, Science and Technology (iBEST), a partnership between Ryerson University and St. Michael’s Hospital, Toronto, Ontario, Canada
- 5Keenan Research Centre for Biomedical Science of St. Michael’s Hospital, Toronto, Ontario, Canada
- ↵*Corresponding authors: Costin Antonescu, Department of Chemistry and Biology, Ryerson University, 350 Victoria Street, Toronto, ON, Canada, M5B 2K3, cantonescu{at}ryerson.ca, and Raffi Karshafian, Department of Physics, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3, karshafian{at}ryerson.ca
Posted February 07, 2019.
Targeted enhancement of flotillin-dependent endocytosis augments cellular uptake and impact of cytotoxic drugs
